Clinical trial
Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
NCT01330108 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- June 30, 2012
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.